| 1 | Technology | XLK | +28.1% |
| 2 | Energy | XLE | +26.1% |
| 3 | Materials | XLB | +13.1% |
| 4 | Real Estate | XLRE | +12.3% |
| 5 | Industrials | XLI | +11.5% |
| 6 | Consumer Staples | XLP | +10.5% |
| 7 | Utilities | XLU | +3.1% |
| 8 | Healthcare | XLV | -1.1% |
| 9 | Consumer Disc. | XLY | -1.5% |
| 10 | Financials | XLF | -2.9% |
| 11 | Communication | XLC | -4.5% |
Intellia Therapeutics is a gene-editing company focused on the development of Crispr/Cas9-based therapeutics. …
| Qtr | Date | EPS Est | Act | Δ | YoY | Rev Est | Act | Δ | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Q1 '26 | 5/11/26 | $-0.90 | $-0.81 | +10.0% | +26% | $0.0B | $0.0B | +6.3% | -9% |
| Q4 '25 | 2/26/26 | $-0.97 | $-0.83 | +14.4% | +35% | $0.0B | $0.0B | +91.1% | +79% |
| Q3 '25 | 11/6/25 | $-1.00 | $-0.92 | +8.0% | +31% | $0.0B | $0.0B | -6.6% | +51% |
| Q2 '25 | 8/7/25 | $-1.02 | $-0.98 | +3.9% | +36% | $0.0B | $0.0B | +13.9% | +105% |
| Q1 '25 | 5/8/25 | $-1.27 | $-1.10 | +13.4% | +2% | $0.0B | $0.0B | +38.7% | -43% |